The Visual Freedom You Deserve
Treat short-sightedness with our innovative Implantable Collamer® Lens.
Made From Collamer®, a Collagen Co-Polymer
Proprietary to STAAR Surgical, Collamer® is biocompatible, stable and flexible, enabling minimally invasive insertion and encouraging harmony with your natural eye.
Wide Range of Treatment
Contact lenses and glasses can be a hassle and limiting. EVO ICL can treat a wide range of prescriptions, from -0.5D to -20D.
EVO vs LASIK vs PRK
When it comes to vision correction, deciding what’s best for your eyes can be difficult. Learn about the differences between procedures and see if EVO ICL is the right fit for you.
It Only Takes 30 Minutes
The EVO ICL procedure is minimally invasive and the lens is implanted through a small opening allowing for a quick procedure and recovery time. With over 2,000,000 lenses distributed worldwide, EVO ICL is quickly becoming a vision correction procedure of choice for many people around the world
Real Life Stories From Real Life Patients
The thing that I love about ICLs is that they are putting a lens in there that can be removed.
Jennifer Puno, Web Designer
I feel like a big part of health is using what your body already has. ICLs is in line with that because it’s keeping your eye completely intact. My eye is still my eye.
Eve Torres Gracie, Jiu Jitsu Instructor
I would never be able to just wake up and go, and now I can literally just roll out of bed and go straight to the farmers market.
Sara Tso, Chef
There’s a few big road blocks to having glasses and being a photographer. Now I’ve got ICLs and I can run out and live my life unhindered.
Andrew Oxenham, Photographer
I had my first opportunity to put my ICLs eyes to the test recently in the Amazon rainforest, and it couldn't have been more exciting to be able to spot rare species better than ever.
Phil Torres, Entomologist, TV Show Host
Ready to Discover Visual Freedom With EVO ICL? Find a Doctor Today
Important Safety Information
The ICL is designed for the correction/reduction of myopia in adults, 21 to 60 years of age, ranging from -0.5 D to -20.0 D with or without astigmatism up to 6.0 D and the correction/reduction of hyperopia in adults, from 21 to 45 years of age, with hyperopia ranging from +0.5 D to +16.0 D with or without astigmatism up to 6.0 D. In order to be sure that your surgeon will use a ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctival irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.
Select Your Region
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.